Growth Metrics

Neogen (NEOG) Common Equity (2016 - 2026)

Neogen has reported Common Equity over the past 17 years, most recently at $2.1 billion for Q1 2026.

  • For Q1 2026, Common Equity fell 20.97% year-over-year to $2.1 billion; the TTM value through Feb 2026 reached $2.1 billion, down 20.97%, while the annual FY2025 figure was $2.1 billion, 34.13% down from the prior year.
  • Common Equity for Q1 2026 was $2.1 billion at Neogen, roughly flat from $2.1 billion in the prior quarter.
  • Over five years, Common Equity peaked at $3.1 billion in Q4 2023 and troughed at $875.5 million in Q1 2022.
  • A 5-year average of $2.4 billion and a median of $2.7 billion in 2024 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: surged 258.91% in 2022 and later tumbled 34.13% in 2025.
  • Year by year, Common Equity stood at $3.1 billion in 2022, then grew by 1.33% to $3.1 billion in 2023, then decreased by 15.2% to $2.7 billion in 2024, then decreased by 21.15% to $2.1 billion in 2025, then dropped by 0.1% to $2.1 billion in 2026.
  • Business Quant data shows Common Equity for NEOG at $2.1 billion in Q1 2026, $2.1 billion in Q4 2025, and $2.1 billion in Q3 2025.